Literature DB >> 22302781

Cholestasis secondary to anabolic steroid use in young men.

Ahmed M Elsharkawy1, Stuart McPherson, Steven Masson, Alastair D Burt, Robert T Dawson, Mark Hudson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302781     DOI: 10.1136/bmj.e468

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach.

Authors:  David E Kleiner
Journal:  Gastroenterol Clin North Am       Date:  2017-06       Impact factor: 3.806

2.  Deltoid compartment syndrome as a complication of lateral decubitus positioning for contralateral elbow surgery in an anabolic steroid abuser.

Authors:  Julian D Wijesuriya; Paul D Cowling; Christopher Izod; David Jc Burton
Journal:  Shoulder Elbow       Date:  2014-04-08

Review 3.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

Review 4.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

Review 5.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

Review 6.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30

7.  Fetal androgen exposure is a determinant of adult male metabolic health.

Authors:  Katarzyna J Siemienowicz; Panagiotis Filis; Sophie Shaw; Alex Douglas; Jennifer Thomas; Sally Mulroy; Forbes Howie; Paul A Fowler; W Colin Duncan; Mick T Rae
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.